I think these ASX blue chips shares are primed for a major rebound in 2026

2025 was not kind to these shares. Here's why things could be better next year.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • CSL Ltd is well-positioned for a rebound due to its robust presence in global healthcare and ongoing investments, despite recent market anxieties and temporary operational challenges.
  • WiseTech Global's CargoWise platform retains strong growth potential amid recent setbacks; with a recovery in sentiment and successful business adjustments, it could experience a significant upswing.
  • The article highlights opportunities arising from market impatience, encouraging a long-term perspective to capitalise on undervalued high-quality stocks.

Every market cycle produces its winners and losers. And sometimes, the losers aren't poor-quality companies at all, they are simply dealing with temporary headwinds.

That's what makes times like these so interesting. Several high-quality ASX blue chips have been marked down over the past year, not because their businesses are broken, but because the market has lost patience.

For investors who are willing to look beyond the next quarter, that disconnect can create attractive entry points.

Here are two ASX blue chip shares I believe are primed for a major rebound in 2026.

Two men laughing while bouncing on bouncy balls

Image source: Getty Images

CSL Ltd (ASX: CSL)

CSL has spent decades earning its reputation as one of the highest-quality companies on the ASX. Its plasma therapies, vaccines, and specialty medicines give it a deeply entrenched position in global healthcare, which is a sector where scale, expertise, and regulatory trust matter enormously.

Yet despite this, CSL shares have been hit hard in 2025. Concerns over a margin recovery at CSL Behring, uncertainty surrounding the Seqirus demerger, weak influenza vaccine rates in the United States, and noise around US tariff policy have clouded what remains a fundamentally strong long-term outlook.

Strip out the market anxiety, and the underlying story hasn't changed for this biotech. Plasma collections continue to rise, new therapies are advancing through its R&D pipeline, and CSL is investing heavily in North American manufacturing to support future growth. The company's earnings power and competitive moat remain intact.

It is rare to see CSL trading at such a meaningful discount to its long-term averages. If sentiment improves in 2026, this blue chip ASX share could be one of the ASX's rebound stories.

Wisetech Global Ltd (ASX: WTC)

WiseTech has transformed global logistics software with its flagship CargoWise platform, which is now used by some of the biggest freight forwarders and supply-chain operators on the planet. Its model is sticky, scalable, and increasingly global, which is the kind of combination tech investors dream about.

However, the past year brought a rare step backwards in market sentiment. Founder controversies, delays to product launches, and a shift to its business model have led to a significant share price pullback. But none of these issues reflect a deterioration in the long-term fundamentals.

CargoWise continues to expand its reach through acquisitions, large enterprise customers are deepening their usage, and WiseTech is still growing at a strong rate.

If its performance improves, it stays clear of further controversies, and transitions successfully to its new business model in 2026, I think the rebound could be sharp for this blue chip ASX share.

Motley Fool contributor James Mickleboro has positions in CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A man in a suit looks serious while discussing business dealings with a couple as they sit around a computer at a desk in a bank home lending scenario.
Blue Chip Shares

2 ASX shares that could benefit from rising interest rates and oil prices

These two shares may be well-placed in the current environment.

Read more »

A person holds strong behind their umbrella as they weather the oncoming storm.
Blue Chip Shares

2 great ASX 200 blue-chip shares I'd buy right now

This looks like a good time to invest, in my view.

Read more »

An elephant standing on a chair looking down at a mouse
Blue Chip Shares

How are Australia's biggest blue-chip stocks performing in 2026?

Which has been the best to own this year?

Read more »

A family sitting on a couch watching Netflix
Blue Chip Shares

The ideal Australian stocks to buy and hold forever

Here are three ASX shares I would consider holding long term.

Read more »

Woman with $50 notes in her hand thinking, symbolising dividends.
Blue Chip Shares

Where to invest $5,000 in Australian shares for the rest of 2026

I think spreading investments across sectors can improve long-term outcomes.

Read more »

Two smiling work colleagues discuss an investment at their office.
Blue Chip Shares

Where I'd put $10,000 in Australian stocks right now

These two beaten down ASX stocks could look attractive for long-term investors.

Read more »

a woman checks her mobile phone against the background of illuminated share market boards with graphs and tables.
Blue Chip Shares

Where I'd invest $10,000 in ASX 200 blue-chip shares right now

When investing in blue chips, I look for strong businesses with long growth runways.

Read more »

Shattered investor with head in hands, with ASX chart in the background.
Blue Chip Shares

Where to invest $20,000 in ASX shares after the market selloff

Market selloffs are hard in the moment but can be incredible buying opportunities.

Read more »